Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Clinical testing of Tbeta4 begins at RegeneRx

April 10, 2003

No Comments

Jerini decapeptide designated orphan drug for angioedema

April 10, 2003

No Comments

Infliximab effective and well tolerated in plaque psoriasis

April 10, 2003

No Comments

New data on alitretinoin and bexarotene in dermatological disorders

April 10, 2003

No Comments

Elidel approved in Switzerland

April 9, 2003

No Comments

Prous Science announces publication of state-of-the-art review: acne vulgaris

April 8, 2003

No Comments

Metvix PDT approved in Australia

April 7, 2003

No Comments

Phase III program under way for Seboride

April 4, 2003

No Comments

Galen enters agreements for psoriasis treatments

April 4, 2003

No Comments

Results reported for azelaic acid 15% gel in rosacea

April 4, 2003

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Dermatologic
RSS

Clinical testing of Tbeta4 begins at RegeneRx

Jerini decapeptide designated orphan drug for angioedema

Infliximab effective and well tolerated in plaque psoriasis

New data on alitretinoin and bexarotene in dermatological disorders

Elidel approved in Switzerland

Prous Science announces publication of state-of-the-art review: acne vulgaris

Metvix PDT approved in Australia

Phase III program under way for Seboride

Galen enters agreements for psoriasis treatments

Results reported for azelaic acid 15% gel in rosacea

Today's news in brief

Today's news in brief

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

Australia’s Celosia heads toward clinic with gene therapy for ALS

Sangamo stock plunges as Pfizer leaves hemophilia partnership

Dermatologic RSS

Dermatologic
RSS